NMRA
Neumora Therapeutics, Inc. · Healthcare
Head of R, D Robert A. Lenz sold $493K of Neumora Therapeutics, Inc.
Sold$492,827
$11.89Price
41,464Shares
−11%Stake
What NMRA did after the filing
- The stock from Thu, Sep 19 close, $12.73
- −10.1%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Oct 31 close.
Traded Tue, Sep 17. Filed Thu, Sep 19, 12:35 PM ET, during the session. Returns use the Sep 19 close and the Oct 31 close. Not investment advice.